Please assess the completion status of the following clinical trial:

Trial Title: Prevention of Atrial Fibrillation Following Esophagectomy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Males or females over the age of 40~* Scheduled to undergo esophagectomy~Exclusion Criteria:~* History of atrial fibrillation~* Prior severe side effects from amiodarone~* Elevated liver enzymes \>3 times the upper limit of normal (UNL)~* Corrected QT interval \> 450 ms~* Receiving class Ia or class III antiarrhythmics

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Amiodarone (Type: EXPERIMENTAL): Intravenous amiodarone
- Control (Type: OTHER): Control

Based on this trial design, predict the completion outcome and termination type (if applicable).